arrow
J

José António Pereira da Silva

universidade de coimbra
H指数:56
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A meta-analysis of smoking and fracture risk to update the FRAX® tool

吸烟与骨折风险的Meta分析,以更新FRAX®工具

2026-03-040
PRE
Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool

骨折家族史与骨折风险:一项更新FRAX®风险评估工具的荟萃分析

2025-08-230
PRE
Dimensionality and Psychometric Properties of the Emotions-Affect Systems ELicitation (EASEL-3) in Fibromyalgia and the General Population: A Cross-Cultural Study

纤维肌痛症和普通人群中情感-情绪系统引发量表(EASEL-3)的维度及心理测量特性:一项跨文化研究

2025-08-010
PRE
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study

疾病相关脑激活预测类风湿关节炎中TNF抑制的临床反应(PreCePra):一项随机、多中心、双盲、安慰剂对照的III期研究

2025-06-230
OAAI
Effects of vitamin D3, omega-3s, and a simple home exercise program on incident vertebral fractures: the DO-HEALTH randomized controlled trial

维生素D3、Omega-3s及简易家庭锻炼方案对椎体骨折发生的影响:DO-HEALTH随机对照试验

2025-06-010
OAAI
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia

EULAR/美国风湿病学会针对关节痛风险阶段发展为类风湿关节炎的风险分层标准

2025-05-080
PRE
Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial

骨质疏松性椎体骨折在社区居住的欧洲老年人中的患病率与发病率:DO-HEALTH试验的观察性分析

2025-04-250
OA
Cognitive function in generally healthy adults age 70 years and older in the 5-country DO-HEALTH study: MMSE and MoCA scores by sex, education and country

在5国DO-HEALTH研究中,年龄在70岁及以上的一般健康成年人的认知功能: 按性别,教育程度和国家划分的MMSE和MoCA得分

2025-03-170
OAAI
Effects of vitamin D3, omega-3s, and a simple strength training exercise program on bone health: the DO-HEALTH randomized controlled trial
2024-04-133
OA
Effects of vitamin D, omega-3 and a simple strength exercise programme in cardiovascular disease prevention: The DO-HEALTH randomized controlled trial
2024-02-014
OAAI